BOOM...New high. IRBT is now one of the anointed tech stocks and money will pour into it for years. Stock will hit new highs year after year no matter what. $500 in 5 years.
In this market, $200 within 18 months...easily.
This is a bubble waiting to burst. Don't invest anymore money. No way is a two billion dollar company with a niche market worth 80-90 dollars a share. Expect a decline by next week.
What does share price have anything to do with the value of the company? Apple was a 2 billion dollar company at some time. This is a double or triple EASY. Read what the CEO said about the exponential growth happening with robot sales this year. Then think about the other robots waiting in the wings, ready to make our lives easier. No brainer.
Market still hasn't caught up here. $150 within 6 months.
Why is a 2 billion dollar company worth 80 dollars a share just because of a good quarter? Damn, the market is stupid.
IRBT is starting to trade like another anointed stock that money will pile into no matter what for many years to come. Looking for a double from here and a $5+ billion mkt. cap within 12 months. 10 years from now IRBT could be a $50+ billion mkt. cap. company. Buy all you can right now.
AXSM (MC $85 M)(Cash $60 M) 5x BIG Phase 3 in various indications targeting large Markets with first interim results in Q3 2017 = 2000% POTENTIAL..UNKNOWN low float Stock !!! A BIG LIFETIME OPPORTUNITY GUYS ! GLTA
Undiscovered and massive undervalued Biotech Stock with lots of Big News on the way.This Stock is brutally undervalued with a Market cap of just $85 million and $60 million in cash .Founder and Ceo is the larget shareholder holding over 7 million shares (30%) more than 50% of O/S is owned by Insider and Institutions which is a great sign .
This undiscovered stock could be the next 10 bagger gem if just one of their 5 ongoing Phase 3 programs is successful .GL
Market-Cap: $85 Million Cash: $60.6 Million(cash runway into the first quarter of 2019.) Price:$3.70
Shares Out: 23 Million
Anticipated Near-Term Clinical Milestones
Clinical Trial Initiations: -- Phase 2/3 clinical trial of AXS-05 in AD agitation (2Q 2017)
Clinical Trial Readouts:
-- Phase 3 COAST-1 trial of AXS-02 in knee OA associated with BMLs, interim analysis (3Q 2017)
-- Phase 3 CREATE-1 trial of AXS-02 in CRPS, interim efficacy analysis (4Q 2017)
-- Phase 3 STRIDE-1 trial of AXS-05 in TRD, top-line data (1Q 2018)
X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks May-2016 1,000 Day Parameter 2,830 NASDAQ Stocks Price Analysis This stock mode of correlation coefficient is 0.5 In other words, the correlation coefficient of the other stock
Zacks said to sale when it was 29 a lot of head winds, so that means wait till it hits 100
If we are to go off the RSI then you could argue that a pull back next day or so could occur on IRBT before rallying up. google awesome-STOCKS - they offer pretty good trade alerrts. you dont have to trade their tickers but it definetly helps you recognize possible patterns for stocks you're trading.
IRBT starting to trade like another anointed stock as it continues to hit new highs no matter what the news. This thing could easily hit $100 as the street just pushed it higher and higher with no regard for fundamentals.
Current market cap is 1.77B and soon to be a 2 Billion dollar company once the stock hits $74 per share. Moving up into a mid-cap stock has it's benefits as mid-cap stocks have proven themselves as once a "small" player to be thriving with further growth opportunities with less risk. Robotic vacuum cleaners are still somewhat niche but is gaining traction and wider adoption as prices continue to come down while the performance continues to improve.